Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease

NCT01427517 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Minnesota

Collaborators